No Data
Express News | Summary of shareholding reductions by listed companies on November 22nd (Table)
On November 25, A-shares investment risk avoidance: ali health shareholder plans to reduce shareholding by no more than 12 million shares.
Chinese health shareholder ali health plans to reduce its shareholding by no more than 12 million shares; Aoruida shareholder Qingcheng Kunshun plans to collectively reduce their shareholding by no more than 3%; Chuangshi technology holding shareholder and actual controller received a notification letter from the procuratorial organ; Jinlong machinery & electronic stated that the reported embezzlement incident involving relevant positions has received a notice of case filing; Ningbo techmation stated that the Italian company EEI does not directly produce and develop complete nuclear fusion devices; Tasly pharmaceutical group has temporarily suspended the clinical trial of AnMaiMu monoclonal antibody.
Chinese Health: Report for the third quarter of 2024
Express News | Huatai Health: Huatai Large Health plans to reduce its shareholding by no more than 1%.
Shareholder Saifu Investment of Huaren Health (301408.SZ) plans to reduce its shareholding by up to 4 million shares.
Huarun Health (301408.SZ) announced that the shareholder Saifu Investment intends to reduce its shareholding in the company, with the specific number of shares to be reduced...
Chinese Health: Semi-Annual Report 2024
No Data
No Data